openPR Logo
Press release

Topical Drug Delivery Market Report Up to 2031

11-02-2021 08:13 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: Visiongain Pharma

Visiongain has published a new report on Topical Drug Delivery Market Report 2021-2031: By Type (Semisolids (Creams, Ointments, Gels, Lotions, Liquids, Solids, Transdermal Products), Route (Dermal, Rectal, Vaginal), Patient Care Setting (Homecare, Hospital, Burn Centre). PLUS Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Download Exclusive Sample of Report @ https://www.visiongain.com/report/topical-drug-delivery-market-2021/#download_sampe_div

The growth of the market is dependent on high prevalence of skin and soft tissue infections, and in increase in eye disease and burns. Hence the presence of alternative dug delivery modes such as oral and injectable routes is expected to restrict the growth of this market.

COVID-19 Impact on Topical Drug Delivery Market
The pandemic COVID 19 is spreading tremendously all over the world. The need of improved patient care and need of drugs such multivitamins vitamin C and antivirus to improve immunity of the patients, is in the huge demand.

Due to increase in pandemic COVID 19 the hospitals medicals and end users are maintaining the stock of various drugs which in-turn is giving boost to this market.

Market Drivers
Due to the high prevalence of skin disease such as psoriasis, skin cancer, and vitiligo which is covering the high population having these disease, as a topical drug delivery is the first line of treatment for the majority of skin diseases the demand for advanced topical products is expected to increase in further years.

The home care settings segment is growing at a rapid pace in this sector because it don’t take patients time for admitting in hospitals , the patients are being cared at home itself and they can save large cost and don’t have to disturb regular work activity of the patients.

Market Opportunities
The delivery of biologics through the transdermal route is one of the emerging trends in topical drug delivery market. The transdermal delivery of large molecules as an alternative to intramuscular, subcutaneous or intravenous routes of administration is expected to provide significant patients.
This increasing trend is encouraging the growth of topical drug delivery market.

Get Detailed TOC @ https://www.visiongain.com/report/topical-drug-delivery-market-2021/#download_sampe_div

Competitive Landscape
Due to the rapid spread of COVID-19 and increasing distress, medicines are being stocked by various end users and patients. This is expected to boost the growth of the topical drug delivery market from 2020–2021. Various companies have witnessed an increase in revenue in Q1 2020 as compared to Q1 2019. For instance, AbbVie registered an increase of 16.8% in its revenue during this period. Likewise, Amgen reported a revenue of USD 6,161 million in Q1 of 2020, an 11% increase as compared to Q1 2019 (USD 5,286 million).

Some of the companies profiled in the report include –Johnson & Johnson (US), Nestlé SA (Switzerland), Novartis AG (Switzerland), GlaxoSmithKline (UK), Bausch Health Companies (Canada), Merck & Co (US), Bayer AG (Germany), Hisamitsu Pharmaceutical (Japan), Glenmark Pharmaceuticals (India), Cipla Ltd (India), Crescita Therapeutics Inc. (Canada), Mylan (US), Encore Dermatology, Inc. (US), LEO Pharma (Denmark), Almirall, S.A (Spain), Aclaris Therapeutics, Inc. (US), Taro Pharmaceutical Industries Ltd. (US), Teligent Pharma (US), Perrigo Pharma (US), Allergan (Ireland), Biofrontera, Inc. (US), Crown Laboratories Inc. (US), Akorn Inc. (US), Ingenus Pharmaceuticals (US), and Sun Pharmaceuticals (India).

Request Customized Report as Per Your Requirements @ https://www.visiongain.com/contact/

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Topical Drug Delivery market and leading companies. You will find data, trends and predictions.

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com

Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Research Insight : https://www.visiongain.com/topical-drug-delivery-industry-analysis/

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Topical Drug Delivery Market Report Up to 2031 here

News-ID: 2450360 • Views: 136

More Releases from Visiongain Pharma

Animal Antimicrobials and Antibiotics Market Report Up to 2031
Visiongain has published a new report on Animal Antimicrobials and Antibiotics Market Report to 2031: Forecasts By Product Type (Penicillin, Tetracycline, Sulfonamides, Quinolones, Macrolides, Cephalosporin, Amingoglycoside, and Others), By Animal Type (Companion Animals and Food-producing Animals), By Mode of Delivery (Oral powder or solutions, Injections, Premix, and Others) PLUS COVID-19 Recovery Scenarios. COVID-19 Impact on Animal Antimicrobials and Antibiotics Market: The COVID-19 pandemic has deleterious affected all the countries and industries. Similarly,
Angioplasty Balloons Market Report Up to 2031
Visiongain has published a new report on Angioplasty Balloons Market Report to 2031: Forecasts By Product Type (Normal, Drug-Eluting, and Cutting & Scoring Balloons), By Application (Coronary Artery Disease and Peripheral Artery Diseases) PLUS COVID-19 Recovery Scenarios. How has COVID-19 Impacted on Angioplasty Balloons Market COVID-19 pandemic adversely affected over 200 countries worldwide. Companies have been pressured to upsurge production capacity and raise the supply of products and other commodities. The pandemic
Anaemia Treatment Market Report Up to 2031
Visiongain has published a new report on Anemia Treatment Market Report to 2031: Forecasts By Anemia Type (Iron Deficiency Anemia, Hemolytic Anemia, Sickle Cell Anemia, Pernicious Anemia, and Thalassemia Anemia), By Drug Type (Bone Marrow Stimulants, Gene Therapy, Iron Chelating Agents, Corticosteroids, Supplements, and Immunotherapy), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) PLUS COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ https://www.visiongain.com/report/anaemia-treatment-market/#download_sampe_div COVID-19 Impact on Anemia Market The COVID-19
Anastomosis Device Market Report Up to 2031
Visiongain has published a new report on Anastomosis Device Market Report to 2031: Forecasts by Type (Surgical Staplers (Manual and Powered), Surgical Sutures (Absorbable Sutures (Synthetic Sutures (Polyglactin 910 Sutures, Poliglecaprone 25 Sutures, Polydioxanone Sutures, Polyglycolic Acid Sutures, and Other Synthetic Sutures), and Natural Sutures), Non-absorbable Sutures (Polypropylene, Nylon, Stainless Steel, and Other Non-absorbable Sutures), Automated Suturing Devices (Disposable and Reusable), Surgical Sealants and Adhesives (Natural/Biological (Fibrin-based, Collagen-based, and Albumin-based)

All 5 Releases


More Releases for COVID

Company Innovation During COVID-19
Centuria Foods, Inc. was able to come out on top during the worldwide COVID-19 pandemic because of its ability to adapt and act quickly to the new normal. The company’s leadership quickly realized this virus was going to be a long term crisis that would result in short term revenue loss. Most clients were wanting to wait and see what was going to happen before moving forward with previously scheduled production.
COVID-19 proof deliveries
DUNA-BIOSHIELD eliminates the risk of contamination without risks for people, residues, odors and without environmental restrictions. It is our hydroalcoholic disinfectant compliant with the directives of the World Health Organization that DUNA has developed, and has been applied since March 2020 to all products departing from its factory in Modena. With the official extension of the state of health emergency on the national territory until October 15th, as well as the
COVID-19 ANALYSIS TELEHEALTH MARKET
Telehealth Market: Overview The telehealth market is riding on the wave of growth. This is because telehealth is no longer an option, but a necessity due to the increasing dangers of COVID-19. The crisis is serving as an opportunity for the telehealth market to grow at a rapid pace. During this uncertain COVID-19 pandemic, telehealth serves as a boon. With a large populace forced to stay at home due to the
Covid 19 Discounts at Imaginology
Imaginology LLC, a Phoenix owned small business, specializing in animation, video and interactive media production, announced that it is offering discounts on their in-studio, live streaming services to businesses affected by Covid-19. Like the businesses they want to help, their business has also been impacted by the pandemic. The staff saw the broad reaching effects of sheltering in place on businesses and families alike and realized the studio is in
PHARMA MANUFACTURING COVID-19 CHALLENGE
New Delhi, 19 June, 2020 - Business Horizons, pharmaceutical publishers, announces the launch of their latest publication titled Pharma Manufacturing Covid-19 Challenge. This is their latest offering in the field of pharmaceutical books, after the highly successful earlier book Pharmaceutical Facility Management. In December 2019, China began noticing a disturbing trend of pneumonia like cases that were fast multiplying in the city of Wuhan, the sprawling capital of central China’s Hubei
COVID-19 UV Light Solution
New York-based MRD Lighting, a major vendor to the international cruise industry, is developing ultraviolet lighting prototypes to combat airborne and surface-transmitted viruses aboard ships. The company, which has consistently innovated in providing a wide array of solutions to cruise lines, is working with subject matter experts in the radiological and epidemiology arenas to provide rapid-response capabilities as the Coronavirus increasingly impacts the cruise industry. "We have been expanding our capabilities and